{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:05:27Z","timestamp":1777651527361,"version":"3.51.4"},"reference-count":49,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>In Fontan circulation, pulmonary arterial hypertension (PAH)-targeted therapies could improve the patients\u2019 exercise capacity. This study aimed to investigate the effects of PAH agents on different exercise parameters in stable Fontan patients by synthesising evidence of randomised controlled trials (RCTs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic search of PubMed, Cochrane Central Register of Controlled Trials and Web of Science databases, as well as of ClinicalTrials.gov, was performed. Primary outcomes were specific cardiopulmonary exercise test parameters: peak oxygen uptake (peak VO<jats:sub>2<\/jats:sub>), peak heart rate (peak HR), the minute ventilation\/produced carbon dioxide (VE\/VCO<jats:sub>2<\/jats:sub>) slope and the oxygen uptake, both measured at the anaerobic threshold (VO<jats:sub>2<\/jats:sub>@AT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five RCTs were included in the analysis including 573 Fontan patients (mean age 21.2 years, 60% male). PAH-targeted therapies did not affect peak VO<jats:sub>2<\/jats:sub> (mean difference (MD) 0.72, 95%\u2009CI \u22120.25 to 1.70) or peak HR (MD \u22120.67, 95%\u2009CI \u22123.81 to 2.47), but resulted in a small, significant improvement in VO<jats:sub>2<\/jats:sub>@AT (standardised MD 0.24, 95%\u2009CI 0.02 to 0.47). VE\/VCO<jats:sub>2<\/jats:sub> slope at the anaerobic threshold was also reduced (MD \u22121.13, 95%\u2009CI \u22122.25 to \u22120.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although PAH-targeted therapies did not affect exercise parameters at maximal effort, they induced slight improvements in indices of submaximal effort, measured at the anaerobic threshold. Pharmacological improvement of submaximal exercise seems to be a more suitable indicator of Fontan individuals\u2019 exercise capacity. Larger RCTs, recruiting specific subpopulations and focusing also on the anaerobic threshold, are warranted to draw more robust conclusions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42022306674.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323166","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T13:20:58Z","timestamp":1698931258000},"page":"552-559","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Pulmonary vasodilators and exercise in Fontan circulation: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct05918211","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-8904","authenticated-orcid":false,"given":"Diamantis","family":"Kosmidis","sequence":"first","affiliation":[{"name":"First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-7280","authenticated-orcid":false,"given":"Alexandra","family":"Arvanitaki","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"},{"name":"Adult Congenital Heart Disease and Pulmonary Hypertension Service, Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0586-6386","authenticated-orcid":false,"given":"Ioannis T","family":"Farmakis","sequence":"additional","affiliation":[{"name":"Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Liakos","sequence":"additional","affiliation":[{"name":"Clinical Research and Evidence-Based Medicine Unit, Aristotle University Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Giannopoulos","sequence":"additional","affiliation":[{"name":"Pediatric Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Ziakas","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-6319","authenticated-orcid":false,"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"2025092002123789000_110.8.552.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)35174-8"},{"key":"2025092002123789000_110.8.552.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)35562-X"},{"key":"2025092002123789000_110.8.552.3","doi-asserted-by":"crossref","first-page":"I157","DOI":"10.1161\/CIRCULATIONAHA.106.676445","article-title":"The Fontan procedure: contemporary techniques have improved long-term outcomes","volume":"116","author":"d\u2019Udekem","year":"2007","journal-title":"Circulation"},{"key":"2025092002123789000_110.8.552.4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/apa.15098","article-title":"Providing a framework of principles for conceptualising the Fontan circulation","volume":"109","author":"Gewillig","year":"2020","journal-title":"Acta Paediatr"},{"key":"2025092002123789000_110.8.552.5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307467"},{"key":"2025092002123789000_110.8.552.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000074210.49434.40"},{"key":"2025092002123789000_110.8.552.7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jtcvs.2018.11.144","article-title":"Evaluation of pulmonary endothelial function in Fontan patients","volume":"158","author":"Latus","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025092002123789000_110.8.552.8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1250124"},{"key":"2025092002123789000_110.8.552.9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jtcvs.2012.11.031","article-title":"Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation","volume":"146","author":"Henaine","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025092002123789000_110.8.552.10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023035","article-title":"Use of pulmonary arterial hypertension therapies in patients with a Fontan circulation: current practice across the United Kingdom","volume":"11","author":"Constantine","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025092002123789000_110.8.552.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.001243"},{"key":"2025092002123789000_110.8.552.12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jtcvs.2017.01.051","article-title":"Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation","volume":"153","author":"Agnoletti","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025092002123789000_110.8.552.13","doi-asserted-by":"crossref","unstructured":"Castaldi B , Bordin G , Padalino M , et al . Hemodynamic impact of pulmonary vasodilators on single ventricle physiology. Cardiovasc Ther 2018;36. doi:10.1111\/1755-5922.12314","DOI":"10.1111\/1755-5922.12314"},{"key":"2025092002123789000_110.8.552.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn215"},{"key":"2025092002123789000_110.8.552.15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00392-014-0694-2","article-title":"Predictors of sildenafil effects on exercise capacity in adolescents and adults with Fontan circulation","volume":"103","author":"Hager","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"2025092002123789000_110.8.552.16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.825472","article-title":"Late Fontan circulatory failure. What drives systemic venous congestion and low cardiac output in adult Fontan patients","volume":"9","author":"Van De Bruaene","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025092002123789000_110.8.552.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq356"},{"key":"2025092002123789000_110.8.552.18","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000812","article-title":"Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review","volume":"5","author":"Udholm","year":"2018","journal-title":"Open Heart"},{"key":"2025092002123789000_110.8.552.19","doi-asserted-by":"crossref","first-page":"2045894018790450","DOI":"10.1177\/2045894018790450","article-title":"The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials","volume":"9","author":"Wang","year":"2019","journal-title":"Pulm Circ"},{"key":"2025092002123789000_110.8.552.20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10741-019-09905-y","article-title":"Pulmonary vasodilator therapy after the Fontan procedure: a meta-analysis","volume":"26","author":"Li","year":"2021","journal-title":"Heart Fail Rev"},{"key":"2025092002123789000_110.8.552.21","article-title":"Exercising with a single ventricle: limitations and therapies","volume":"9","author":"Haley","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"2025092002123789000_110.8.552.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025092002123789000_110.8.552.23","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2025092002123789000_110.8.552.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38636.593461.68"},{"key":"2025092002123789000_110.8.552.25","unstructured":"Li T , Higgins JPT , Deeks JJ . Chapter 5: collecting data. In: Cochrane Handb. Syst. Rev. Interv. Version 6.2. 2021."},{"key":"2025092002123789000_110.8.552.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025092002123789000_110.8.552.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"2025092002123789000_110.8.552.28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard Dersimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025092002123789000_110.8.552.29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res Synth Methods"},{"key":"2025092002123789000_110.8.552.30","unstructured":"Deeks JJ , Higgins JPT , Altman DG . Chapter 10: analysing data and undertaking meta-analyses. In: Cochrane Handb. Syst. Rev. Interv. Version 6.2. 2021."},{"key":"2025092002123789000_110.8.552.31","unstructured":"Biasedurn S . Package \u201emeta\u201f; 2022."},{"key":"2025092002123789000_110.8.552.32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias visualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"2025092002123789000_110.8.552.33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.119.044352","article-title":"Results of the FUEL trial","volume":"141","author":"Goldberg","year":"2020","journal-title":"Circulation"},{"key":"2025092002123789000_110.8.552.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008441"},{"key":"2025092002123789000_110.8.552.35","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft017"},{"key":"2025092002123789000_110.8.552.36","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.amjcard.2016.02.024","article-title":"Effect of Ambrisentan on exercise capacity in adult patients after the Fontan procedure","volume":"117","author":"Cedars","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025092002123789000_110.8.552.37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.981746"},{"key":"2025092002123789000_110.8.552.38","doi-asserted-by":"crossref","first-page":"2045894018811148","DOI":"10.1177\/2045894018811148","article-title":"Pulmonary vasodilator therapy as treatment for patients with a Fontan circulation: the emperor's new clothes?","volume":"8","author":"Ridderbos","year":"2018","journal-title":"Pulm Circ"},{"key":"2025092002123789000_110.8.552.39","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017615","article-title":"Pulmonary vasodilator therapy for patients after Fontan procedure: a protocol for a systematic review and meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2025092002123789000_110.8.552.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3181e52e69"},{"key":"2025092002123789000_110.8.552.41","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201612-997FR"},{"key":"2025092002123789000_110.8.552.42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00246-020-02465-1","article-title":"Exercise capacity and predictors of performance after Fontan: results from the pediatric heart network Fontan 3 study","volume":"42","author":"Goldberg","year":"2021","journal-title":"Pediatr Cardiol"},{"key":"2025092002123789000_110.8.552.43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00184.2014"},{"key":"2025092002123789000_110.8.552.44","doi-asserted-by":"crossref","first-page":"H335","DOI":"10.1152\/ajpheart.00322.2018","article-title":"Ventilatory and sensory responses to incremental exercise in adults with a Fontan circulation","volume":"316","author":"Guenette","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025092002123789000_110.8.552.45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/chd.12694","article-title":"A restrictive ventilatory pattern is common in patients with univentricular heart after Fontan palliation and associated with a reduced exercise capacity and quality of life","volume":"14","author":"Callegari","year":"2019","journal-title":"Congenit Heart Dis"},{"key":"2025092002123789000_110.8.552.46","doi-asserted-by":"crossref","first-page":"764273","DOI":"10.3389\/fcvm.2021.764273","article-title":"The \u201cSuper-Fontan\u201d phenotype: characterizing factors associated with high physical performance","volume":"8","author":"Tran","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025092002123789000_110.8.552.47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2023.05.010","article-title":"Prevalence and clinical correlates and characteristics of \u201cSuper Fontan\"","volume":"263","author":"Ohuchi","year":"2023","journal-title":"Am Heart J"},{"key":"2025092002123789000_110.8.552.48","doi-asserted-by":"crossref","first-page":"131288","DOI":"10.1016\/j.ijcard.2023.131288","article-title":"Benefit of exercise in patients with a Fontan circulation","volume":"392","author":"Arvanitaki","year":"2023","journal-title":"Int J Cardiol"},{"key":"2025092002123789000_110.8.552.49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jamacardio.2019.5459","article-title":"Diastolic heart failure in patients with the Fontan circulation: a review","volume":"5","author":"Budts","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:12:46Z","timestamp":1758359566000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,3,22]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/heartjnl-2023-323166"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323166","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}